ArticleFrontiers in oncology2022

GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma.

Sen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.